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Abstract
Background: Echocardiography is not recommended for routine pre-surgical evaluation but may have value for
patients at high risk of major adverse cardiovascular events (MACE). The objective of this study was to evaluate
whether pre-operative echocardiography is associated with lower risk of post-operative MACE among patients
with coronary artery disease.
Methods: Using administrative and registry data, we examined associations of echocardiography within 3 months prior
to surgery with postoperative MACE (myocardial infarction, revascularization, or death within 30 days) among patients
with coronary artery disease undergoing elective, non-cardiac surgeries in the United States Veterans Affairs healthcare
system in 2000–2012.
Results: Echocardiography preceded 4,378 (16.4 %) of 26,641 surgeries. MACE occurred within 30 days following
944 (3.5 %) surgeries. A 10 % higher case-mix adjusted rate of pre-operative echocardiography assessed at the
hospital level was associated with a hospital-level risk of MACE that was 1.0 % (95 % confidence interval [CI] 0.1 %, 2.0 %)
higher overall and 1.7 % (95 % CI 0.2 %, 3.2 %) higher among patients with recent myocardial infarction, valvular heart
disease, or heart failure. At the patient level, pre-operative echocardiography was associated with an odds ratio for MACE
of 1.9 (95 % CI 1.7, 2.2) overall and 1.8 (95 % CI 1.5, 2.2) among patients with recent myocardial infarction, valvular heart
disease, or heart failure adjusting for MACE risk factors.
Conclusions: Pre-operative echocardiography was not associated with lower risk of post-operative MACE, even in a high
risk population. Future guidelines should encourage pre-operative echocardiography only in specific patients
with cardiovascular disease among whom findings can be translated into effective changes in care.
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Background
Echocardiography is commonly performed prior to surgery
[1], and abnormalities detected through echocardiography
may be associated with higher risk of major adverse cardiac
events (MACE) following surgery [2, 3]. Although the
information obtained through echocardiography could in-
form care, in the general surgical population, pre-operative
echocardiography provides little additional prognostic
information, and its usefulness in guiding peri-operative
treatment is unclear [2, 3]. For this reason, echocardiog-
raphy is not recommended for routine pre-operative evalu-
ation among patients without cardiovascular disease (CVD)
[2–5]. In previous studies, pre-operative echocardiography
has been associated with higher 30-day and 1-year mortality
and longer length of stay [1, 6], which may be a result of
higher risk patients being more likely to receive echocardi-
ography. Additional testing, treatments, or treatment delays
or cancellations triggered by echocardiography results may
also contribute to these observations.
Preexisting CVDs, particularly heart failure (HF), valvular
heart disease (VHD), and recent myocardial infarction
(MI), are risk factors for MACE following non-cardiac
surgery [3], and the proportion of surgical patients with
CVD, including HF, VHD, and recent MI, is increasing [7].
Echocardiography is well-established as a valuable tool for
diagnosis and evaluation of symptoms of many CVDs, and
pre-operative echocardiography may be helpful for guiding
peri-operative care among patients with established CVD
[2, 3, 5, 7]. We therefore hypothesized that pre-operative
echocardiography is associated with a reduced risk of
post-operative MACE among patients with coronary ar-
tery disease, particularly those who also have HF, VHD,
or recent MI.
We examined the associations echocardiography per-
formed in the 3 months prior to surgery (hereafter called
pre-operative echocardiography) with post-operative MACE
among patients with coronary artery disease undergo-
ing elective, non-cardiac surgery in the United States
Veterans Affairs (VA) healthcare system. Because con-
cerning findings on echocardiography may cause patients
and clinicians to avoid surgery, we additionally examined
the correlations between echocardiography use, surgical
volume, and surgery cancellations.
Methods
Study population
We conducted a retrospective cohort study within the
VA healthcare system during fiscal years 2000-2012. The
study protocol was reviewed and approved by the local
VA Institutional Review Board of each co-author and
conforms to the ethical guidelines of the 1975 Declaration
of Helsinki. Because this study included only data rou-
tinely collected as part of clinical care, the Institutional
Review Boards approved a waiver of informed consent.
The study population has been previously described [8].
This cohort was initially assembled to examine MACE fol-
lowing non-cardiac surgery in patients within 2 years of
placement of a coronary stent [8]. Briefly, patients undergo-
ing placement of coronary stents within the VA healthcare
system during fiscal years 2000 through 2012 were identi-
fied using International Classification of Diseases 9th edition
(ICD9) procedure codes 36.06 for bare metal stents and
36.07 for drug eluting stents in VA administrative data.
Non-cardiac surgery in the 2 years following stent place-
ment was identified through the VA Surgical Quality Im-
provement Program (VASQIP) registry. For each patient
with a stent, 2 patients without stents undergoing non-
cardiac surgery were included, matched on fiscal year
of surgery, age within 5 years, work relative value unit
(a measure of surgery complexity) within 5 units, surgi-
cal specialty, pre-operative creatinine >2 mg/dl, classifi-
cation of high risk surgery (suprainguinal, intrathoracic,
or intraperitoneal operations), and the components that
make up the Revised Cardiac Risk Index (coronary artery
disease, HF, stroke, chronic kidney disease, and insulin-
dependent diabetes) [9]. All of the patients had a history
of coronary artery disease. For the current study, we fur-
ther limited the cohort to 8,823 stent/surgery patients and
17,818 matched surgery-only patients undergoing elective
surgeries. Patients could be included in the cohort more
than once if they had multiple surgeries. Patients with a
history of MI in the 6 months prior to surgery or a history
of HF or valvular disease in the past 24 months were con-
sidered a particularly high risk population. To examine
the association between echocardiography and surgical
volume and number of surgery cancellations, we exam-
ined a cohort of 126,773 individuals who had coronary
stents placed, identified as described above.
Pre-operative echocardiography
Echocardiography within the 3 months prior to surgery
was identified by Current Procedure Terminology (CPT)
codes (93312, 93315, 93318, 93350, 93351, 93303, 93304,
93306, 93307, 93308, 93320, 93321, 93325) and ICD9
procedure codes (88.72) in administrative data. Because
a recent echocardiogram may influence the decision to
perform another echocardiogram, we also identified echo-
cardiography in the 3 to 12 months prior to surgery.
Covariates
Covariates of interest were obtained from VASQIP (demo-
graphics, social factors, pre-operative comorbidities, and
operative characteristics). Additional comorbidities were
identified from the administrative data based on ICD9
diagnosis codes. For patients with surgeries in fiscal year
2005 and later, prescriptions for beta-blockers, statins,
aspirin, clopidogrel, warfarin, renin-angiotensin system
inhibitors, calcium channel blockers, diuretics, amiodarone,
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digoxin, and nitrates extending into or through the 30 days
prior to surgery were identified using VA pharmacy data.
Post-operative MACE
MACE within 30 days following non-cardiac surgery was
defined as an MI recorded in VASQIP or administrative
data, revascularization recorded in administrative data,
or death recorded in VASQIP or administrative data. This
definition of MACE has been used previously in this
population [8].
Statistical analysis
Patient and operative characteristics were compared by risk
group and receipt of pre-operative echocardiography. Tests
for differences conducted using Chi-square tests for pro-
portions and Wilcoxon Rank Sum for continuous variables.
These analyses were performed using SAS version 9.3.
For hospitals with at least 25 included surgeries, hospital-
level echocardiography rates were calculated as the per-
centage of patients who received an echocardiogram in
the 3 months prior to surgery. Of the 146 VA hospitals,
we included 117 with at least 25 surgeries in the overall
population, 87 with at least 25 surgeries in the popula-
tion with recent MI, HF, or VHD, and 117 with at least
25 surgeries in the population without recent MI, HF,
or VHD. To adjust the hospital-level echocardiography
rates for case-mix, we constructed mixed-effects logistic
regression models with the outcome of pre-operative echo-
cardiography, random intercepts for the hospitals, and
patient and operative characteristics as the independent
variables [10]. Values of the random intercepts were calcu-
lated using empirical Bayesian estimates [11], and case-mix
adjusted echocardiography rates for each hospital were cal-
culated using the intercept for that hospital and the mean
values of the patient and operative characteristics across
hospitals. Observed and case-mix adjusted hospital-level
echocardiography rates were plotted using a density plot.
These analyses were repeated stratified by MACE risk
group. Plots were developed using the R-program statistical
software and GGPLOT2 package [12].
Linear regression was used to model MACE risk dif-
ferences associated with a 10 % higher hospital-level rate
of pre-operative echocardiography and by quartiles of
hospital-level rate of pre-operative echocardiography.
Models were repeated for case-mix adjusted rate of
pre-operative echocardiography. The association between
patient-level receipt of pre-operative echocardiography and
MACE following surgery was estimated using logistic re-
gression with a random intercept for hospital. Backwards
stepwise selection was used to identify covariates from the
patient and operative characteristics expected to be
associated with echocardiography and/or MACE. All
models were constructed using R-program statistical
software and the lme4 package [13, 14].
In the cohort of patients who received a coronary stent,
we calculated the hospital-level correlation between rate of
pre-operative echocardiography use and surgical volume
and number of surgery cancellations in the 2 years follow-
ing coronary stent placement. Additionally, we examined
the percentage of planned surgeries which were cancelled
in individuals with echocardiography in the 3 months prior
to the planned surgery and the percentage in the overall
population.
Results
Among 26,641 elective, non-cardiac surgeries, 4,378
(16.4 %) had pre-operative echocardiography (Table 1).
Among patients with high-risk conditions (recent MI,
HF, or VHD), 28.7 % had pre-operative echocardiography,
compared to 12.8 % of patients without those conditions.
The median time between echocardiography and surgery
was 35 days (interquartile range 10-63 days). Patients who
received pre-operative echocardiography were more likely
to be ≥60 years of age and to have a history of diabetes,
peripheral vascular disease, coronary artery bypass graft,
chronic kidney disease, arrhythmia, and pacemakers. Pa-
tients with coronary stents were slightly less likely to have
pre-operative echocardiography than patients without
stents. Compared to patients without pre-operative echo-
cardiography, the patients with pre-operative echocardiog-
raphy were more likely to have inpatient surgery, higher
work relative value units, high risk surgeries, and, among
the group with coronary stents, a shorter time from stent-
ing to surgery.
Before adjusting for case-mix, VA hospitals varied widely
in the use of pre-operative echocardiography (mean 13.8 %,
range 0.0 %–30.6 %, standard deviation 6.8 %) (Fig. 1). After
adjusting for case-mix, the variability decreased (mean
14.3 %, range 8.6–25.5 %, standard deviation 3.1 %).
Hospitals were more variable in the use of pre-operative
echocardiography among patients with recent MI, HF, or
VHD than among patients without these conditions. There
was a moderate correlation (r= 0.53) between hospital-level
use of pre-operative echocardiography among patients with
and without recent MI, HF, or VHD (Additional file 1:
Figure S1).
In the 30 days following non-cardiac surgery, 944
patients (3.5 %) experienced MACE (7.5 % with pre-
operative echocardiography versus 2.8 % without pre-
operative echocardiography, p < 0.001). Before adjusting
for case-mix, higher hospital rates of pre-operative echo-
cardiography were associated with higher hospital rates
of MACE within 30 days of surgery (Fig. 2). For every
10 % higher rate of pre-operative echocardiography, the
hospital-level 30-day risk of MACE was 1.25 % (95 %
confidence interval [CI] 0.77 %, 1.74 %) higher. Associations
between echocardiography and MACE were stronger com-
paring patients with HF, VHD, or recent MI to patients
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Table 1 Characteristics of surgical patients in the Veterans Affairs health system by whether or not they receive pre-operative
echocardiographya
Patients with heart failure, valvular heart
disease, recent myocardial infarction
Patients without heart failure, valvular heart
disease, recent myocardial infarction
Echocardiogram in the 3 months prior to surgery Yes (N = 1,732) No (N = 4,307) Yes (N = 2,646) No (N = 17,956) P-Value
Demographics
Age
Years, Median (25th percentile-75th percentile) 67.0 (61.0–75.0) 67.0 (60.0–75.0) 65.0 (60.0–73.0) 64.0 (59.0–72.0) <0.001
<60 339 (19.6) 968 (22.5) 601 (22.7) 4,949 (27.6) <0.001
≥60 1,393 (80.4) 3,339 (77.5) 2,045 (77.3) 13,007 (72.4)
Race
Black 194 (11.5) 451 (10.8) 315 (12.3) 1,910 (11.0) 0.11
Other 25 (1.5) 54 (1.3) 32 (1.3) 177 (1.0)
White 1,471 (87.0) 3,686 (88.0) 2,207 (86.4) 15,321 (88.0)
Gender
Female 27 (1.6) 94 (2.2) 40 (1.5) 401 (2.2) 0.04
Male 1,705 (98.4) 4,213 (97.8) 2,606 (98.5) 17,555 (97.8)
Health status
Echocardiogram in the 3 to 12 Months Prior to Surgery
No 1,105 (63.8) 2,318 (53.8) 2,254 (85.2) 14,561 (81.1) <0.001
Yes 627 (36.2) 1,989 (46.2) 392 (14.8) 3,395 (18.9)
Myocardial infarction within 6 months
No 997 (57.6) 2,465 (57.2) 2,646 (100.0) 17,956 (100.0) <0.001
Yes 735 (42.4) 1,842 (42.8) 0 (0.0) 0 (0.0)
Heart failure hospitalization within 6 months
No 1,108 (64.0) 3,115 (72.3) 2,646 (100.0) 17,956 (100.0) <0.001
Yes 624 (36.0) 1,192 (27.7) 0 (0.0) 0 (0.0)
History of heart failure
No 784 (45.3) 2,381 (55.3) 1,974 (74.6) 15,444 (86.2) <0.001
Yes 948 (54.7) 1,924 (44.7) 672 (25.4) 2,472 (13.8)
Valvular heart disease
No 882 (50.9) 2,329 (54.1) 2,646 (100.0) 17,956 (100.0) <0.001
Yes 850 (49.1) 1,978 (45.9) 0 (0.0) 0 (0.0)
Coronary artery stents
None 918 (53.0) 2,231 (51.8) 1,905 (72.0) 12,764 (71.1) <0.001
Bare metal stents 433 (25.0) 1,222 (28.4) 382 (14.4) 2,563 (14.3)
Drug-eluting stents 371 (21.4) 830 (19.3) 350 (13.2) 2,563 (14.3)
Both bare metal and drug-eluting stents 10 (0.6) 24 (0.6) 9 (0.3) 66 (0.4)
Diabetes
None 1,031 (59.5) 2,830 (65.7) 1,723 (65.1) 12,360 (68.8) <0.001
Non-insulin dependent 308 (17.8) 754 (17.5) 483 (18.3) 3,165 (17.6)
Insulin dependent 393 (22.7) 723 (16.8) 440 (16.6) 2,431 (13.5)
Peripheral vascular disease
No 1,063 (61.4) 2,854 (66.3) 1,760 (66.5) 13,772 (76.7) <0.001
Yes 669 (38.6) 1,453 (33.7) 886 (33.5) 4,184 (23.3)
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Table 1 Characteristics of surgical patients in the Veterans Affairs health system by whether or not they receive pre-operative
echocardiographya (Continued)
Stroke
No 1,681 (97.1) 4,230 (98.3) 2,544 (96.2) 17,673 (98.6) <0.001
Yes 51 (2.9) 75 (1.7) 102 (3.9) 243 (1.4)
Hypertension
No 117 (9.2) 277 (10.1) 196 (9.9) 1,772 (14.2) <0.001
Yes 1,154 (90.8) 2,458 (89.9) 1,784 (90.1) 10,749 (85.9)
Coronary artery bypass grafting
No 1,600 (92.4) 4,024 (93.4) 2,554 (96.5) 17,467 (97.3) <0.001
Yes 132 (7.6) 283 (6.6) 92 (3.5) 489 (2.7)
Chronic kidney disease
No 1,268 (73.2) 3,514 (81.6) 2,229 (84.2) 16,083 (89.6) <0.001
Yes 464 (26.8) 793 (18.4) 417 (15.8) 1,873 (10.4)
Arrhythmia
No 789 (45.6) 2,207 (51.2) 1,681 (63.5) 12,899 (71.8) <0.001
Yes 943 (54.5) 2,100 (48.8) 965 (36.5) 5,057 (28.2)
Pacemaker
No 1,686 (97.3) 4,225 (98.1) 2,618 (98.9) 17,828 (99.3) <0.001
Yes 46 (2.7) 82 (1.9) 28 (1.1) 128 (0.7)
Cardioverter defibrillator
No 1,697 (98.0) 4,235 (98.3) 2,629 (99.4) 17,870 (99.5) <0.001
Yes 35 (2.0) 72 (1.7) 17 (0.6) 86 (0.5)
Operative Characteristics
Inpatient/Outpatient, n (%)
Outpatient 456 (26.4) 1,536 (35.8) 751 (28.5) 8,092 (45.1) <0.001
Inpatient 1,273 (73.6) 2,761 (64.3) 1,886 (71.5) 9,837 (54.9)
Work Relative Value Unit
Median (25th percentile-75th percentile) 18.2 (11.8–22.6) 15.4 (9.6–21.8) 19.6 (11.8–23.3) 15.3 (8.4–21.8) <0.001
<10 762 (44.0) 1,887 (43.8) 1,124 (42.5) 6,821 (38.0) <0.001
10–20 372 (21.5) 1,177 (27.3) 514 (19.4) 5,847 (32.6)
>20 597 (34.5) 1,243 (28.9) 1,008 (38.1) 5,288 (29.5)
High Risk Surgery
No 1,286 (74.3) 3,332 (77.4) 1,909 (72.2) 14,417 (80.3) <0.001
Yes 446 (25.8) 975 (22.6) 737 (27.9) 3,539 (19.7)
Procedure Type
Digestive 402 (23.2) 1,141 (26.5) 593 (22.4) 4,959 (27.6) <0.001
Eye/Ear/Skin 31 (1.8) 85 (2.0) 38 (1.4) 299 (1.7)
Genital/Urinary 206 (11.9) 607 (14.1) 285 (10.8) 2,616 (14.6)
Musculoskeletal 272 (15.7) 828 (19.2) 475 (18.0) 4,465 (24.9)
Nervous 34 (2.0) 119 (2.8) 88 (3.3) 709 (4.0)
Other 50 (2.9) 102 (2.4) 78 (3.0) 422 (2.4)
Respiratory 82 (4.7) 146 (3.4) 156 (5.9) 509 (2.8)
Vascular 655 (37.8) 1,279 (29.7) 933 (35.3) 3,977 (22.2)
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without these conditions. After adjusting for case-mix,
associations were attenuated and without a clear pattern of
risk across quartiles. For every 10 % higher rate of pre-
operative echocardiography, the hospital-level 30-day risk
of MACE was 1.02 % (95 % CI 0.07 %, 1.97 %) higher in the
overall population and 1.73 % (95 % CI 0.22 %, 3.24 %)
higher in the high risk population.
In patient-level analyses, pre-operative echocardiography
was associated with a higher risk of MACE at 30 days (ad-
justed odds ratio 1.92, 95 % CI 1.66, 2.23) in the overall
population after adjusting for risk factors for MACE (Fig. 3).
The higher risk of MACE associated with pre-operative
echocardiography was observed in those with and with-
out recent MI, HF, or VHD. In sensitivity analyses, re-
sults were consistent after adjusting for pre-operative
medication use among patients who had surgeries in
2005–2012 (not shown).
Hospital-level use of echocardiography was not associ-
ated with hospital surgical volume (r = -0.05, p = 0.59) or
hospital number of surgery cancellations (r = -0.03, p =
0.74) in patients with coronary stents. The proportion of
surgeries cancelled was 25 % in patients who received
pre-operative echocardiography compared to an average
cancellation rate of 21 %. The majority of cancellations
(90.6 %) occurred within 7 days of the planned surgery
date with 51.7 % occurring on the same day and 80.6 %
occurring within 48 h.
Discussion
In this population of veterans with coronary artery disease,
16 % underwent echocardiography in the 3 months prior to
elective, non-cardiac surgery (29 % among patients with
recent MI, VHD, or HF). Contrary to our hypothesis, pre-
operative echocardiography was not associated with lower
risk of post-operative MACE either in the overall popula-
tion or in those with recent MI, HF, or VHD. In fact, both
hospital-level and patient-level use of pre-operative echo-
cardiography was associated with a higher risk of MACE.
Our results are consistent with 2 previous studies in
general surgical populations. In the United States Medicare
population, patients who received tests of ventricular func-
tion, including echocardiography, had higher 30-day and 1-
year mortality following vascular surgery than patients who
did not [6]. In a population-based study from Ontario, pre-
operative echocardiography was associated with increased
risk of 30-day and 1-year mortality and longer length of
stay, even among patients with HF [1]. It is possible that
patients would have had even higher risk of MACE without
changes to management initiated following echocardi-
ography or that the higher risk associated with echocardi-
ography reflects patient risk factors that were not fully
Table 1 Characteristics of surgical patients in the Veterans Affairs health system by whether or not they receive pre-operative
echocardiographya (Continued)
Time to Surgery Since Stent
Days, Median (25th percentile-75th percentile) 132.0 (63.0–370.0) 184.0 (104.5–433.0) 347.0 (92.0–515.0) 406.0 (251.0–552.0)
None 100 (5.8) 130 (3.0) 79 (3.0) 173 (1.0) <0.001
<6 Weeks 214 (12.4) 287 (6.7) 103 (3.9) 266 (1.5) <0.001
6 Weeks to 3 Months 166 (9.6) 611 (14.2) 41 (1.6) 341 (1.9)
3 to 6 Months 123 (7.1) 389 (9.0) 169 (6.4) 1,405 (7.8)
6 to 12 Months 211 (12.2) 659 (15.3) 349 (13.2) 3,007 (16.8)
>12 Months 918 (53.0) 2,231 (51.8) 1,905 (72.0) 12,764 (71.1)
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Fig. 1 Facility variation in use of pre-operative echocardiography in
the Veterans Affairs Healthcare System. Smoothed distribution of
pre-operative echocardiography rates by hospital. Of the 146 Veterans
Affairs hospitals, 117 with at least 25 surgeries in the overall population,
87 with at least 25 surgeries in the population with recent MI, HF, or
VHD, and 117 with at least 25 surgeries in the population without recent
MI, HF, or VHD were included
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accounted for in statistical analysis. However, it is also
possible that echocardiography led to changes or delays in
care that could have contributed to the increased risk of
MACE. In a prior study, patients who received pre-
operative echocardiography were more likely to receive
new prescriptions for beta-blockers, statins, and renin-
angiotensin system inhibitors [1]. Although these medica-
tions can be beneficial for chronic management and may
globally reduce cardiovascular risk, recent initiation may
be harmful in some patients undergoing surgery [15].
Echocardiography is widely indicated for patients with
suspected new or worsening CVD [2]. However, clin-
ical guidelines have recommended against routine pre-
operative echocardiography in patients without CVD
since at least 2002 [16]. In recent years, avoiding routine
pre-operative echocardiography among patients without
CVD has received particular attention as part of appropri-
ate use criteria and the Choosing Wisely campaign because
of increased costs and lack of value in guiding surgical care
[2–4, 17]. The guidelines and recommendations are less
clear on the value of pre-operative echocardiography in
patients with CVD, like the patients with coronary ar-
tery disease included in the current study. Additionally,
guidelines do not always have a strong impact on patient
care. A recent study of United States nationally representa-
tive data from 1997–2010 found that there was little change
in the routine utilization of pre-operative radiography,
hematocrit, urinalysis, and cardiac stress testing following
Overall population
  Quartile 1 (Reference)
  Quartile 2
  Quartile 3
  Quartile 4
Patients with HF, VHD, or recent MI
  Quartile 1 (Reference)
  Quartile 2
  Quartile 3
  Quartile 4
Patients without HF, VHD, or recent MI
  Quartile 1 (Reference)
  Quartile 2
  Quartile 3
  Quartile 4





Fig. 2 Association between hospital-level variation in pre-operative echocardiography and post-operative major adverse cardiac events. MACE:
Major adverse cardiac event, HF: Heart failure, VHD: Valvular heart disease, MI: Myocardial infarction. Quartile ranges: Overall population unadjusted ≤9.72 %,
10.00–14.06 %, 14.19–18.84 %, and ≥19.01 %; Overall population case mix-adjusted ≤12.70 %, 12.75–14.20 %, 14.25–15.97 %, and ≥16.00 %; Patients with
heart failure, valvular heart disease, recent myocardial infarction unadjusted ≤18.18 %, 18.46–24.86 %, 25.00–30.43 %, and ≥31.11 %; Patients with heart
failure, valvular heart disease, recent myocardial infarction case mix-adjusted ≤23.45 %, 23.47–25.11 %, 25.11–27.23 %, and ≥27.49 %; Patients without heart
failure, valvular heart disease, recent myocardial infarction unadjusted ≤6.06 %, 6.11–9.85 %, 9.88–12.94 %, and ≥12.95 %; Patients without heart failure,
valvular heart disease, recent myocardial infarction case mix-adjusted ≤9.04 %, 9.04–9.67 %, 9.67–10.52 %, and ≥10.53 %
30−Day MACE
  Overall population
  Patients with HF, VHD, or recent MI
  Patients without HF, VHD, or recent MI
0.5 1 1.5 2 2.5 3
Higher risk of MACELower risk of MACE
Odds Ratio
Fig. 3 Association between patient level pre-operative echocardiography and post-operative major adverse cardiac events. MACE: Major adverse
cardiac event, HF: Heart failure, VHD: Valvular heart disease, MI: Myocardial infarction. Models included a random intercept for hospital and adjusted for
echocardiogram during the 3 to 12 months prior to surgery, age at surgery, recent myocardial infarction, history of heart failure, history of chronic kidney
disease, history of arrhythmia, surgery case status, surgery admission status, work relative value unit, year of surgery, procedure type, and an indicator for
whether the surgery was a high risk procedure
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recommendations against their use, but pre-operative
electrocardiogram use did decline after professional soci-
eties recommended against it [18].
This study had several strengths, include the large popu-
lation treated in an integrated health system. However,
there are also important limitations to this observational,
non-randomized study that prevent us from drawing con-
clusions about the causal effect of pre-operative echocardi-
ography. Although we adjusted for MACE risk factors
through case-mix adjustment in hospital-level analysis and
multivariable models in patient-level models, there may be
residual confounding by indication, where patients who
receive the test have higher underlying risk. We did not
find associations between use of pre-operative echocardiog-
raphy and cancellations of surgeries. Nor did we find an as-
sociation between hospital pre-operative echocardiography
use and surgical volume. However, we could only detect
cancellations of schedule surgeries; echocardiography could
have resulted in surgeries never being scheduled. We could
not determine whether echocardiography was performed as
part of a pre-operative evaluation or for another clinical
indication. In addition, results of the echocardiograms were
not available. Because the data came from the VA health
system, there were few women included.
Conclusions
In conclusion, pre-operative echocardiography was common
among this population of patients with coronary artery dis-
ease undergoing elective, non-cardiac surgery. Pre-operative
echocardiography was not associated with a lower risk of
post-operative MACE either in the overall population or in
the high risk subgroup with recent MI, VHD, or HF. These
results suggest that routine pre-operative echocardiography
may not reduce MACE even in high risk populations.
Future guidelines should encourage pre-operative echo-
cardiography only in specific patients among whom find-
ings can be translated into effective changes in care.
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